SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
33 hedge funds and large institutions have $80M invested in scPharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
+2
Holders Change %
+6.45%
% of All Funds
0.51%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
10
Reduced
9
Closed
3
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$19K
Top Buyers
Top Sellers
| 1 |
JGC
J. Goldman & Co
New York
|
-$2.12M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$198K |
| 3 |
E
Ergoteles
New York
|
-$180K |
| 4 |
HF
HRT Financial
New York
|
-$107K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$102K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Osaic Holdings
Scottsdale,
Arizona
| $20K | +$256 | +50 | +1% |
|
27
UBS Group
Zurich,
Switzerland
| $11K | +$6.88K | +1,410 | +167% |
|
28
Bank of America
Charlotte,
North Carolina
| $6K | +$92 | +18 | +2% |
|
29
Simplex Trading
Chicago,
Illinois
| $2K | +$2K | +539 | New |
|
30
BNP Paribas Financial Markets
Paris,
France
| $1.92K | +$1.39K | +277 | +261% |
|
|
E
31
Ergoteles
New York
| – | -$180K | -27,116 | Closed |
|
|
HF
32
HRT Financial
New York
| – | -$107K | -16,189 | Closed |
|
33
Barclays
London,
United Kingdom
| – | -$5K | -814 | Closed |
|